LEVI 04Alternative Names: p75NTR-Fc
Latest Information Update: 01 Aug 2016
At a glance
- Originator Levicept
- Class Analgesics; Recombinant fusion proteins
- Mechanism of Action Nerve growth factor receptor modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Musculoskeletal pain; Pain
Most Recent Events
- 01 Aug 2016 Preclinical trials in Musculoskeletal pain in United Kingdom (Parenteral)
- 01 Aug 2016 Preclinical trials in Pain in United Kingdom (Parenteral)